Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-pick disease type C

Sharon Zhou, Cristin Davidson, Robert McGlynn, Gloria Stephney, Kostantin Dobrenis, Marie T. Vanier, Steven U. Walkley

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Niemann-Pick disease type C (NPC) is a severe neurovisceral lysosomal storage disorder caused by defects in NPC1 or NPC2 proteins. Although numerous studies support the primacy of cholesterol storage, neurons of double-mutant mice lacking both NPC1 and an enzyme required for synthesis of all complex gangliosides (β1,4GalNAc transferase) have been reported to exhibit dramatically reduced cholesterol sequestration. Here we show that NPC2-deficient mice lacking this enzyme also exhibit reduced cholesterol, but that genetically restricting synthesis to only a-series gangliosides fully restores neuronal cholesterol storage to typical disease levels. Examining the subcellular locations of sequestered compounds in neurons lacking NPC1 or NPC2 by confocal microscopy revealed that cholesterol and the two principal storage gangliosides (GM2 and GM3) were not consistently co-localized within the same intracellular vesicles. To determine whether the lack of GM2 and GM3 co-localization was due to differences in synthetic versus degradative pathway expression, we generated mice lacking both NPC1 and lysosomal β-galactosidase, and therefore unable to generate GM2 and GM3 in lysosomes. Double mutants lacked both gangliosides, indicating that each is the product of endosomal/lysosomal processing. Unexpectedly, GM1 accumulation in double mutants increased compared to single mutants consistent with a direct role for NPC1 in ganglioside salvage. These studies provide further evidence that NPC1 and NPC2 proteins participate in endosomal/lysosomal processing of both sphingolipids and cholesterol.

Original languageEnglish (US)
Pages (from-to)890-902
Number of pages13
JournalAmerican Journal of Pathology
Volume179
Issue number2
DOIs
StatePublished - Aug 2011

Fingerprint

Type C Niemann-Pick Disease
Gangliosides
Cholesterol
G(M2) Ganglioside
G(M3) Ganglioside
Galactosidases
Neurons
Sphingolipids
Enzymes
Transferases
Lysosomes
Confocal Microscopy
Proteins

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-pick disease type C. / Zhou, Sharon; Davidson, Cristin; McGlynn, Robert; Stephney, Gloria; Dobrenis, Kostantin; Vanier, Marie T.; Walkley, Steven U.

In: American Journal of Pathology, Vol. 179, No. 2, 08.2011, p. 890-902.

Research output: Contribution to journalArticle

Zhou, Sharon ; Davidson, Cristin ; McGlynn, Robert ; Stephney, Gloria ; Dobrenis, Kostantin ; Vanier, Marie T. ; Walkley, Steven U. / Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-pick disease type C. In: American Journal of Pathology. 2011 ; Vol. 179, No. 2. pp. 890-902.
@article{2f776764edf447cf842a4675ce4299e1,
title = "Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-pick disease type C",
abstract = "Niemann-Pick disease type C (NPC) is a severe neurovisceral lysosomal storage disorder caused by defects in NPC1 or NPC2 proteins. Although numerous studies support the primacy of cholesterol storage, neurons of double-mutant mice lacking both NPC1 and an enzyme required for synthesis of all complex gangliosides (β1,4GalNAc transferase) have been reported to exhibit dramatically reduced cholesterol sequestration. Here we show that NPC2-deficient mice lacking this enzyme also exhibit reduced cholesterol, but that genetically restricting synthesis to only a-series gangliosides fully restores neuronal cholesterol storage to typical disease levels. Examining the subcellular locations of sequestered compounds in neurons lacking NPC1 or NPC2 by confocal microscopy revealed that cholesterol and the two principal storage gangliosides (GM2 and GM3) were not consistently co-localized within the same intracellular vesicles. To determine whether the lack of GM2 and GM3 co-localization was due to differences in synthetic versus degradative pathway expression, we generated mice lacking both NPC1 and lysosomal β-galactosidase, and therefore unable to generate GM2 and GM3 in lysosomes. Double mutants lacked both gangliosides, indicating that each is the product of endosomal/lysosomal processing. Unexpectedly, GM1 accumulation in double mutants increased compared to single mutants consistent with a direct role for NPC1 in ganglioside salvage. These studies provide further evidence that NPC1 and NPC2 proteins participate in endosomal/lysosomal processing of both sphingolipids and cholesterol.",
author = "Sharon Zhou and Cristin Davidson and Robert McGlynn and Gloria Stephney and Kostantin Dobrenis and Vanier, {Marie T.} and Walkley, {Steven U.}",
year = "2011",
month = "8",
doi = "10.1016/j.ajpath.2011.04.017",
language = "English (US)",
volume = "179",
pages = "890--902",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-pick disease type C

AU - Zhou, Sharon

AU - Davidson, Cristin

AU - McGlynn, Robert

AU - Stephney, Gloria

AU - Dobrenis, Kostantin

AU - Vanier, Marie T.

AU - Walkley, Steven U.

PY - 2011/8

Y1 - 2011/8

N2 - Niemann-Pick disease type C (NPC) is a severe neurovisceral lysosomal storage disorder caused by defects in NPC1 or NPC2 proteins. Although numerous studies support the primacy of cholesterol storage, neurons of double-mutant mice lacking both NPC1 and an enzyme required for synthesis of all complex gangliosides (β1,4GalNAc transferase) have been reported to exhibit dramatically reduced cholesterol sequestration. Here we show that NPC2-deficient mice lacking this enzyme also exhibit reduced cholesterol, but that genetically restricting synthesis to only a-series gangliosides fully restores neuronal cholesterol storage to typical disease levels. Examining the subcellular locations of sequestered compounds in neurons lacking NPC1 or NPC2 by confocal microscopy revealed that cholesterol and the two principal storage gangliosides (GM2 and GM3) were not consistently co-localized within the same intracellular vesicles. To determine whether the lack of GM2 and GM3 co-localization was due to differences in synthetic versus degradative pathway expression, we generated mice lacking both NPC1 and lysosomal β-galactosidase, and therefore unable to generate GM2 and GM3 in lysosomes. Double mutants lacked both gangliosides, indicating that each is the product of endosomal/lysosomal processing. Unexpectedly, GM1 accumulation in double mutants increased compared to single mutants consistent with a direct role for NPC1 in ganglioside salvage. These studies provide further evidence that NPC1 and NPC2 proteins participate in endosomal/lysosomal processing of both sphingolipids and cholesterol.

AB - Niemann-Pick disease type C (NPC) is a severe neurovisceral lysosomal storage disorder caused by defects in NPC1 or NPC2 proteins. Although numerous studies support the primacy of cholesterol storage, neurons of double-mutant mice lacking both NPC1 and an enzyme required for synthesis of all complex gangliosides (β1,4GalNAc transferase) have been reported to exhibit dramatically reduced cholesterol sequestration. Here we show that NPC2-deficient mice lacking this enzyme also exhibit reduced cholesterol, but that genetically restricting synthesis to only a-series gangliosides fully restores neuronal cholesterol storage to typical disease levels. Examining the subcellular locations of sequestered compounds in neurons lacking NPC1 or NPC2 by confocal microscopy revealed that cholesterol and the two principal storage gangliosides (GM2 and GM3) were not consistently co-localized within the same intracellular vesicles. To determine whether the lack of GM2 and GM3 co-localization was due to differences in synthetic versus degradative pathway expression, we generated mice lacking both NPC1 and lysosomal β-galactosidase, and therefore unable to generate GM2 and GM3 in lysosomes. Double mutants lacked both gangliosides, indicating that each is the product of endosomal/lysosomal processing. Unexpectedly, GM1 accumulation in double mutants increased compared to single mutants consistent with a direct role for NPC1 in ganglioside salvage. These studies provide further evidence that NPC1 and NPC2 proteins participate in endosomal/lysosomal processing of both sphingolipids and cholesterol.

UR - http://www.scopus.com/inward/record.url?scp=80052510182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052510182&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2011.04.017

DO - 10.1016/j.ajpath.2011.04.017

M3 - Article

VL - 179

SP - 890

EP - 902

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -